Pulmonary arteriovenous malformations (PAVMs) ORwi.81213 In this paper we aim to address the size of this difference, using data from three new families (fig 2) and 16 families previously published.7 10 11 Diagnosis of HHT in the three new families was made by the presence of two of: recurrent epistaxis, mucocutaneous telangiectasis, and an affected first degree relative. Pulse oximetry was performed according to the method described by Hughes4 to detect PAVMs. Three subjects from family 5 had a chest x ray and lung perfusion scans. Clinical details of the thirteen families assessed by our group were all collected before linkage data were available.
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For the newly assessed families, microsatellite markers were run using accepted techniques and analysis of results was performed using MLINK or LINKMAP.
Of the 16 families included, eight families are not linked to endoglin on chromosome 9 and eight families show evidence of linkage. The majority of people in this group (93/120) came from families large enough to achieve a lod score of greater than 3. The data are summarised in the table.
In the families linked to endoglin, 35/120 (29-2%) had pulmonary arteriovenous malformations. In the unlinked families, 2/69 (2 9%) had PAVMs. The difference between these two groups is highly significant (x2 = 19-2, 1 df, p<0001).
In the endoglin linked group many of the patients had symptomatic PAVMs. There may be several small asymptomatic PAVMs in the non-endoglin population, even though 36/69 were screened by pulse oximetry. This is an unlikely source ofbias as more careful screening of the endoglin population would also be expected to turn up a greater number of asympto- 
